EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of Potent Quinazolinone Inhibitors Against SARS‐CoV‐2 Mpro via an Integrated Computational Strategy

Renato Araújo da Costa, Alberto Soares Vanny, Arlan da Silva Gonçalves, Renilson Castro de Barros, Marinete Sardiha, João Augusto Pereira da Rocha, Elaine Cristina Medeiros da Rocha, Luciane do Socorro Nunes dos Santos Brasil, Davi do Socorro Barros Brasil

ChemistrySelect · 2026-03 · 11 (11)

DOI: 10.1002/slct.202506174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 16.03.2026. Verfasst von Renato Araújo da Costa und 8 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 remains a primary target for antiviral drug discovery. In this study, an integrated computational workflow—comprising molecular docking, triplicate 200 ns molecular dynamics (MD) simulations, Molecular Mechanics–Generalized Born Surface Area (MM/GBSA) binding free energy calculations, and free energy landscape (FEL) analysis—was employed to evaluate potential Mpro inhibitors. Five compounds exhibited higher predicted affinities than the crystallographic reference inhibitor 3W, with compounds 9g and 11e emerging as the most promising candidates. MD simulations demonstrated that both ligands enhanced the structural stability of Mpro, as evidenced by low root‐mean‐square deviation (RMSD) values, reduced root‐mean‐square fluctuation (RMSF) in key regions, and the maintenance of persistent hydrogen‐bond networks. Notably, compound 9g maintained stable interactions with the critical catalytic residue Glu166. MM/GBSA analysis yielded favorable binding free energies (Δ G bind ) of −38.84 kcal/mol for 9g and −32.52 kcal/mol for 11e, while FEL mapping confirmed their capacity to stabilize the protease in deep, energetically favorable conformational minima. Furthermore, the computational predictions correlated strongly with experimental IC50 data, validating the robustness of the applied workflow. These results provide molecular‐level insights into the potent inhibitory activity of 9g and 11e, identifying them as viable lead scaffolds for the development of optimized anti‐SARS‐CoV‐2 therapeutics.

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Costa, R. A. D., Vanny, A. S., Gonçalves, A. D. S., Barros, R. C. D., Sardiha, M., Rocha, J. A. P. D., Rocha, E. C. M. D., Brasil, L. D. S. N. D. S., & Brasil, D. D. S. B. (2026). Discovery of Potent Quinazolinone Inhibitors Against SARS‐CoV‐2 Mpro via an Integrated Computational Strategy. ChemistrySelect, 11(11). https://doi.org/10.1002/slct.202506174

Vancouver

Costa RAD, Vanny AS, Gonçalves ADS, Barros RCD, Sardiha M, Rocha JAPD, et al. Discovery of Potent Quinazolinone Inhibitors Against SARS‐CoV‐2 Mpro via an Integrated Computational Strategy. ChemistrySelect. 2026;11(11). doi:10.1002/slct.202506174

BibTeX
@article{Costa2026,
  author = {Costa, Renato Araújo da and Vanny, Alberto Soares and Gonçalves, Arlan da Silva and Barros, Renilson Castro de and Sardiha, Marinete and Rocha, João Augusto Pereira da and Rocha, Elaine Cristina Medeiros da and Brasil, Luciane do Socorro Nunes dos Santos and Brasil, Davi do Socorro Barros},
  title = {Discovery of Potent Quinazolinone Inhibitors Against SARS‐CoV‐2 Mpro via an Integrated Computational Strategy},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {11},
  doi = {10.1002/slct.202506174}
}
Kostenlos starten →